Clinical Trial Update: OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study [NA]

View source ↗

Summary

This clinical trial aims to overcome immunosuppression and rebalance the immune response in ovarian cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Gynaecologisch Oncologisch Centrum Zuid | Conditions: Ovarian Neoplasms, Ovarian Cancer | NA | Status: RECRUITING